Medinet Co Ltd
TSE:2370

Watchlist Manager
Medinet Co Ltd Logo
Medinet Co Ltd
TSE:2370
Watchlist
Price: 40 JPY Market Closed
Market Cap: 10.6B JPY
Have any thoughts about
Medinet Co Ltd?
Write Note

Medinet Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medinet Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Medinet Co Ltd
TSE:2370
Accrued Liabilities
ÂĄ32.6m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
-2%
CMIC Holdings Co Ltd
TSE:2309
Accrued Liabilities
ÂĄ1.7B
CAGR 3-Years
38%
CAGR 5-Years
24%
CAGR 10-Years
13%
C
Chiome Bioscience Inc
TSE:4583
Accrued Liabilities
ÂĄ18.1m
CAGR 3-Years
-10%
CAGR 5-Years
2%
CAGR 10-Years
-10%
Precision System Science Co Ltd
TSE:7707
Accrued Liabilities
ÂĄ44.1m
CAGR 3-Years
-16%
CAGR 5-Years
44%
CAGR 10-Years
20%
CellSource Co Ltd
TSE:4880
Accrued Liabilities
ÂĄ132.7m
CAGR 3-Years
18%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Accrued Liabilities
ÂĄ255.7m
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
N/A
No Stocks Found

Medinet Co Ltd
Glance View

Market Cap
10.3B JPY
Industry
Life Sciences Tools & Services

MEDINET Co., Ltd. engages in cell processing business. The company is headquartered in Ota-Ku, Tokyo-To and currently employs 83 full-time employees. The company went IPO on 2003-10-08. The company operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. The company also provides comprehensive support services for immune cell therapy.

Intrinsic Value
7.7 JPY
Overvaluation 81%
Intrinsic Value
Price

See Also

What is Medinet Co Ltd's Accrued Liabilities?
Accrued Liabilities
32.6m JPY

Based on the financial report for Jun 30, 2024, Medinet Co Ltd's Accrued Liabilities amounts to 32.6m JPY.

What is Medinet Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
-2%

Over the last year, the Accrued Liabilities growth was 9%. The average annual Accrued Liabilities growth rates for Medinet Co Ltd have been 11% over the past three years , 9% over the past five years , and -2% over the past ten years .

Back to Top